These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9018282)

  • 1. The complicated task of monitoring vaccine safety.
    Ellenberg SS; Chen RT
    Public Health Rep; 1997; 112(1):10-20; discussion 21. PubMed ID: 9018282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vaccine Safety Datalink project.
    DeStefano F;
    Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking vaccine-safety inquiries to detect signals and monitor public concerns.
    Miller E; Batten B; Hampton L; Campbell SR; Gao J; Iskander J
    Pediatrics; 2011 May; 127 Suppl 1():S87-91. PubMed ID: 21502241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.
    Ball R; Horne D; Izurieta H; Sutherland A; Walderhaug M; Hsu H
    Pediatrics; 2011 May; 127 Suppl 1():S31-8. PubMed ID: 21502249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.
    Chen RT; DeStefano F; Davis RL; Jackson LA; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Vadheim CM; Ward JI; Marcy SM
    Bull World Health Organ; 2000; 78(2):186-94. PubMed ID: 10743283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.
    Kanesa-thasan N; Shaw A; Stoddard JJ; Vernon TM
    Pediatrics; 2011 May; 127 Suppl 1():S16-22. PubMed ID: 21502248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflicts of interest in vaccine safety research.
    DeLong G
    Account Res; 2012; 19(2):65-88. PubMed ID: 22375842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surveillance of secondary effects of vaccination].
    Duclos P
    Sante; 1994; 4(3):215-20. PubMed ID: 7921691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of routine childhood vaccinations. An epidemiological review.
    Chen RT; Mootrey G; DeStefano F
    Paediatr Drugs; 2000; 2(4):273-90. PubMed ID: 10946416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congress examines childhood vaccine safety.
    Dove A
    Nat Med; 1999 Sep; 5(9):970. PubMed ID: 10471261
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004.
    Davila JC; Payne DC; Zhang Y; Rose CE; Aranas A; Hill AN; Ruscio B; McNeil MM
    Vaccine; 2008 Mar; 26(12):1577-84. PubMed ID: 18295379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Essential to monitor vaccine safety].
    Heijbel H
    Lakartidningen; 2001 Sep; 98(36):3777-8. PubMed ID: 11586806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.